ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Joseph B. Zwischenberger
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brunston, R. L.
Right arrow Articles by Bidani, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brunston, R. L., Jr
Right arrow Articles by Bidani, A.
Related Collections
Right arrowRelated Articles

Ann Thorac Surg 1997;64:1599-1604
© 1997 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Total Arteriovenous CO2 Removal: Simplifying Extracorporeal Support for Respiratory Failure

Robert L. Brunston, Jr, MD, Joseph B. Zwischenberger, MD, Weike Tao, MD, Victor J. Cardenas, Jr, MD, Daniel L. Traber, PhD, Akhil Bidani, MD, PhD

Departments of Surgery, Medicine, and Anesthesiology, University of Texas Medical Branch and Shriners Burns Institute, Galveston, Texas

Background. To reduce the complexity, complications, and cost of conventional extracorporeal membrane oxygenation, we have developed a technique of simplified arteriovenous extracorporeal CO2 removal (AVCO2R) with a low-resistance membrane gas exchanger for total CO2 removal to provide lung rest in the setting of severe respiratory failure.

Methods. We initially used AVCO2R in healthy animals to quantify the gas exchange capabilities of the system and establish ventilator management protocols for the subsequent studies of AVCO2R in a large animal model of respiratory failure secondary to a severe smoke inhalation injury.

Results. In healthy sheep the maximum spontaneous arteriovenous flow ranged from 1,350 to 1,500 mL/min, whereas CO2 removal plateaued at a blood flow of approximately 1,000 mL/min in which 112 ± 3 mL/min CO2 was removed, allowing an 84% reduction in the minute ventilation of from 6.9 ± 0.8 L/min to 1.1 ± 0.4 L/min (p < 0.01) without triggering hypercapnia. A subsequent reduction in extracorporeal flow at a reduced minute volume led to the development of hypercapnia only if it decreased to less than 500 mL/min. We also applied AVCO2R in mechanically ventilated sheep with a severe smoke inhalation injury and removed 95% (111 ± 4 mL/min) of the total CO2 production. This allowed the minute ventilation to be reduced by 95% and the peak inspiratory pressures by 52% (both p < 0.05) over 6 hours and produced no adverse hemodynamic effects. The partial pressure of arterial oxygen was maintained above 100 mm Hg at a maximally reduced minute volume. The mean AVCO2R flow was 1,213 ± 29 mL/min, averaging 27% ± 1% of the cardiac output.

Conclusions. We conclude that AVCO2R in a simple arteriovenous shunt is a less complicated technique than extracorporeal membrane oxygenation and is capable of total CO2 removal that allows a significant reduction in the minute ventilation and peak airway pressure during severe respiratory failure.


Related Articles

Is Extracorporeal CO2Removal an Option in the Treatment of Adult Respiratory Distress Syndrome?
Jean Deslauriers and John A. Awad
Ann. Thorac. Surg. 1997 64: 1581-1582. [Extract] [Full Text]

Discussion
Ann. Thorac. Surg. 1997 64: 1604-1605. [Extract] [Full Text]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The Society of Thoracic Surgeons.